{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T20:49:21Z","timestamp":1785703761394,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.jaip.2026.07.010","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:33:39Z","timestamp":1784072019000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6450-3182","authenticated-orcid":false,"given":"Monica G.","family":"Lawrence","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vy H.D.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan S.","family":"Orange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2026.07.010_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10875-017-0404-8","article-title":"Health-related quality of life in adult patients with common variable immunodeficiency disorders and impact of treatment","volume":"37","author":"Rider","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib2","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fimmu.2014.00605","article-title":"Longitudinal study on health-related quality of life in a cohort of 96 patients with common variable immune deficiencies","volume":"5","author":"Tabolli","year":"2014","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib3","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1080\/1750743X.2024.2367924","article-title":"A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescents","volume":"16","author":"Fasshauer","year":"2024","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaip.2026.07.010_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.anai.2025.10.026","volume":"136","author":"Orange","year":"2026","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib5","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.jaip.2016.07.012","article-title":"Development and initial validation of a questionnaire to measure health-related quality of life of adults with common variable immune deficiency: the CVID_QoL questionnaire","volume":"4","author":"Quinti","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.07.010_bib6","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/j.jaci.2016.11.029","article-title":"Construction and validation of a novel disease-specific quality-of-life instrument for patients with primary antibody deficiency disease (PADQOL-16)","volume":"139","author":"Ballow","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1007\/s10875-015-0196-7","article-title":"Perceived health in patients with primary immune deficiency","volume":"35","author":"Seeborg","year":"2015","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10875-016-0367-1","article-title":"Increased incidence of fatigue in patients with primary immunodeficiency disorders: prevalence and associations within the US Immunodeficiency Network Registry","volume":"37","author":"Hajjar","year":"2017","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib9","first-page":"402129","article-title":"Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment Consortium","author":"Thakar","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.jaip.2026.07.010_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/GJMW5701","article-title":"Newborn screening for severe combined immunodeficiency in the NHS newborn blood spot screening programme: a systematic review","volume":"30","author":"Westwood","year":"2026","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.jaip.2026.07.010_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ijns8040053","article-title":"Psychosocial issues related to newborn screening: a systematic review and synthesis","volume":"8","author":"Tluczek","year":"2022","journal-title":"Int J Neonatal Screen"},{"key":"10.1016\/j.jaip.2026.07.010_bib12","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s10897-017-0150-3","article-title":"Psychosocial distress and knowledge deficiencies in parents of children in Ireland who carry an altered cystic fibrosis gene","volume":"27","author":"Quigley","year":"2018","journal-title":"J Genet Couns"},{"key":"10.1016\/j.jaip.2026.07.010_bib13","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/s12026-020-09131-x","article-title":"Jeffrey's insights: Jeffrey Modell Foundation's global genetic sequencing pilot program to identify specific primary immunodeficiency defects to optimize disease management and treatment","volume":"68","author":"Quinn","year":"2020","journal-title":"Immunol Res"},{"key":"10.1016\/j.jaip.2026.07.010_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.anai.2019.08.016","article-title":"Practical approach to genetic testing for primary immunodeficiencies","volume":"123","author":"Chinen","year":"2019","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1279112","article-title":"Current genetic diagnostics in inborn errors of immunity","volume":"12","author":"von Hardenberg","year":"2024","journal-title":"Front Pediatr"},{"key":"10.1016\/j.jaip.2026.07.010_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.humimm.2021.02.011","article-title":"Next-generation sequencing for inborn errors of immunity","volume":"82","author":"Lee","year":"2021","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s00439-020-02131-9","article-title":"Incomplete penetrance in primary immunodeficiency: a skeleton in the closet","volume":"139","author":"Gruber","year":"2020","journal-title":"Hum Genet"},{"key":"10.1016\/j.jaip.2026.07.010_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.jaip.2026.02.026","article-title":"What we have here is a failure to communicate: interleukin-12 \/ interferon-gamma axis defects and Mendelian susceptibility to mycobacterial disease","volume":"14","author":"Johnston","year":"2026","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.07.010_bib19","doi-asserted-by":"crossref","DOI":"10.70962\/jhi.20250137","article-title":"How I Treat: Infections and inborn errors of immunity-prevention, diagnosis, and treatment","volume":"2","author":"Freeman","year":"2026","journal-title":"J Hum Immun"},{"key":"10.1016\/j.jaip.2026.07.010_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.jaci.2019.01.051","article-title":"Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies","volume":"144","author":"Milito","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib21","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1007\/s10875-020-00841-3","article-title":"Immunoglobulin replacement therapy versus antibiotic prophylaxis as treatment for incomplete primary antibody deficiency","volume":"41","author":"Smits","year":"2021","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib22","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jaip.2024.12.024","article-title":"If and when to consider prophylactic immunoglobulin replacement therapy in secondary hypogammaglobulinemia","volume":"13","author":"Otani","year":"2025","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2026.07.010_bib23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/cei.12915","article-title":"When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach","volume":"188","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib24","first-page":"1311699","article-title":"Treatment of hypogammaglobulinemia in adults: a scoring system to guide decisions on immunoglobulin replacement","author":"Agarwal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2010-01-254417","article-title":"How I treat common variable immune deficiency","volume":"116","author":"Cunningham-Rundles","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.07.010_bib27","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2147\/PPA.S303279","article-title":"Patient preferences for subcutaneous versus intravenous administration of treatment for chronic immune system disorders: a systematic review","volume":"15","author":"Overton","year":"2021","journal-title":"Patient Prefer Adherence"},{"issue":"suppl 3","key":"10.1016\/j.jaip.2026.07.010_bib28","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jaci.2016.09.023","article-title":"Update on the use of immunoglobulin in human disease: a review of evidence","volume":"139","author":"Perez","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13223-024-00939-y","article-title":"Immunoglobulin replacement therapy in patients with primary and secondary immunodeficiencies: impact of infusion method on immunoglobulin-specific perceptions of quality of life and treatment satisfaction","volume":"21","author":"Mallick","year":"2025","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2019.100068","article-title":"Impact of IVIG vs. SCIG on IgG trough level and infection incidence in primary immunodeficiency diseases: a systematic review and meta-analysis of clinical studies","volume":"12","author":"Shrestha","year":"2019","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2026.07.010_bib31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10875-019-0592-5","article-title":"Health-related quality of life in patients with CVID under different schedules of immunoglobulin administration: prospective multicenter study","volume":"39","author":"Pulvirenti","year":"2019","journal-title":"J Clin Immunol"},{"issue":"suppl 1","key":"10.1016\/j.jaip.2026.07.010_bib32","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1093\/jpids\/piy016","article-title":"Prevention of infectious complications in patients with chronic granulomatous disease","volume":"7","author":"Slack","year":"2018","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.jaip.2026.07.010_bib33","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJM199102213240801","article-title":"A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease","volume":"324","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaip.2026.07.010_bib34","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/CDLI.6.3.420-424.1999","article-title":"Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils","volume":"6","author":"Ahlin","year":"1999","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib35","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1182\/bloodadvances.2025016213","article-title":"Interferon gamma rebalances immunopathological signatures in chronic granulomatous disease through metabolic rewiring","volume":"9","author":"Bruno","year":"2025","journal-title":"Blood Adv"},{"key":"10.1016\/j.jaip.2026.07.010_bib36","article-title":"Hematopoietic stem cell transplantation for inborn errors of immunity: 30-year single-center experience","volume":"14","author":"Dell'Orso","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib37","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood.2022015506","article-title":"Hematopoietic stem cell transplantation for adolescents and adults with inborn errors of immunity: an EBMT IEWP study","volume":"140","author":"Albert","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.07.010_bib38","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2023-001866","article-title":"Shared decision-making for children with medical complexity in community health services: a scoping review","volume":"7","author":"Jacobs","year":"2023","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/j.jaip.2026.07.010_bib39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s10875-024-01854-y","article-title":"Pre-transplant immune dysregulation predicts for poor outcome following allogeneic haematopoietic stem cell transplantation in adolescents and adults with inborn errors of immunity (IEI)","volume":"45","author":"Fox","year":"2025","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaip.2026.07.010_bib40","doi-asserted-by":"crossref","unstructured":"Arnold DE, Eissa H, Dunn E, Cuvelier GDE, Wright NAM, Marsh RA, et al. IMPACT (Immune Monitoring and Phenotype Assessment of Clinical Trajectory) for patients with inborn errors of immunity from the Primary Immune Deficiency Treatment Consortium (PIDTC) [online ahead of print June 3, 2026]. J Allergy Clin Immunol Pract. doi:10.1016\/j.jaip.2026.05.025.","DOI":"10.1016\/j.jaip.2026.05.025"},{"key":"10.1016\/j.jaip.2026.07.010_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1182\/blood-2018-09-876284","article-title":"The Hematopoietic Cell Transplant Comorbidity Index predicts survival after allogeneic transplant for nonmalignant diseases","volume":"133","author":"Thakar","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.07.010_bib42","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood.2020008187","article-title":"How I use allogeneic HSCT for adults with inborn errors of immunity","volume":"138","author":"Burns","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jaip.2026.07.010_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.29099","article-title":"Decision making for hematopoietic stem cell transplantation in pediatric, adolescent, and young adult patients with a hemoglobinopathy-shared or not?","volume":"68","author":"Mekelenkamp","year":"2021","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaip.2026.07.010_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.690309","article-title":"How to facilitate decision-making for hematopoietic stem cell transplantation in patients with hemoglobinopathies. The perspectives of healthcare professionals","volume":"9","author":"Mekelenkamp","year":"2021","journal-title":"Front Pediatr"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005908?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219826005908?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:59:49Z","timestamp":1785700789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219826005908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":44,"alternative-id":["S2213219826005908"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2026.07.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shared Decision-Making and Health-Related Quality of Life in the Diagnosis and Management of Patients With Inborn Errors of Immunity","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2026.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Academy of Allergy, Asthma & Immunology","name":"copyright","label":"Copyright"}]}}